Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.
2.
3.

Adhesion of viridans group streptococci to sialic acid-, galactose- and N-acetylgalactosamine-containing receptors.

Takahashi Y, Ruhl S, Yoon JW, Sandberg AL, Cisar JO.

Oral Microbiol Immunol. 2002 Aug;17(4):257-62.

PMID:
12121477
5.

Reducing the burden of oral and pharyngeal cancers.

Winn DM, Sandberg AL, Horowitz AM, Diehl SR, Gutkind S, Kleinman DV.

J Calif Dent Assoc. 1998 Jun;26(6):445-51, 454. Review.

PMID:
9791281
6.

Scientific progress in understanding oral and pharyngeal cancers.

Winn DM, Diehl SR, Horowitz AM, Gutkind S, Sandberg AL, Kleinman DV.

J Am Dent Assoc. 1998 Jun;129(6):713-8. Review.

PMID:
9631611
8.
9.

Specific inhibitors of bacterial adhesion: observations from the study of gram-positive bacteria that initiate biofilm formation on the tooth surface.

Cisar JO, Takahashi Y, Ruhl S, Donkersloot JA, Sandberg AL.

Adv Dent Res. 1997 Apr;11(1):168-75. Review.

PMID:
9524453
10.

Recognition of immunoglobulin A1 by oral actinomyces and streptococcal lectins.

Ruhl S, Sandberg AL, Cole MF, Cisar JO.

Infect Immun. 1996 Dec;64(12):5421-4.

11.

Lectin recognition of host-like saccharide motifs in streptococcal cell wall polysaccharides.

Cisar JO, Sandberg AL, Abeygunawardana C, Reddy GP, Bush CA.

Glycobiology. 1995 Oct;5(7):655-62.

PMID:
8608267
12.

Putative glycoprotein and glycolipid polymorphonuclear leukocyte receptors for the Actinomyces naeslundii WVU45 fimbrial lectin.

Sandberg AL, Ruhl S, Joralmon RA, Brennan MJ, Sutphin MJ, Cisar JO.

Infect Immun. 1995 Jul;63(7):2625-31.

13.

Immunochemical and functional studies of Actinomyces viscosus T14V type 1 fimbriae with monoclonal and polyclonal antibodies directed against the fimbrial subunit.

Cisar JO, Barsumian EL, Siraganian RP, Clark WB, Yeung MK, Hsu SD, Curl SH, Vatter AE, Sandberg AL.

J Gen Microbiol. 1991 Aug;137(8):1971-9.

PMID:
1683401
14.

Cooperative complement- and bacterial lectin-initiated bactericidal activity of polymorphonuclear leukocytes.

Kurashima C, Sandberg AL, Cisar JO, Mudrick LL.

Infect Immun. 1991 Jan;59(1):216-21.

15.
16.

Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.

Cisar JO, Vatter AE, Clark WB, Curl SH, Hurst-Calderone S, Sandberg AL.

Infect Immun. 1988 Nov;56(11):2984-9.

17.

Identification of C3d receptors on Candida albicans.

Calderone RA, Linehan L, Wadsworth E, Sandberg AL.

Infect Immun. 1988 Jan;56(1):252-8.

18.
19.

Molecular basis of bacterial adhesion in the oral cavity.

Mergenhagen SE, Sandberg AL, Chassy BM, Brennan MJ, Yeung MK, Donkersloot JA, Cisar JO.

Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S467-74. Review.

PMID:
2891180
20.

Binding of Actinomyces naeslundii to glycosphingolipids.

Brennan MJ, Joralmon RA, Cisar JO, Sandberg AL.

Infect Immun. 1987 Feb;55(2):487-9.

21.

Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes.

Sandberg AL, Mudrick LL, Cisar JO, Brennan MJ, Mergenhagen SE, Vatter AE.

Infect Immun. 1986 Nov;54(2):472-6.

23.

Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations.

Obrist R, Obrecht JP, Bast RC Jr, Sandberg AL.

Adv Exp Med Biol. 1985;186:827-32. No abstract available.

PMID:
4050600
24.

Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.

Brennan MJ, Cisar JO, Vatter AE, Sandberg AL.

Infect Immun. 1984 Nov;46(2):459-64.

25.
26.
27.

In vitro and in vivo effects of anti-tumor antibody covalently coupled to a chemotactic peptide.

Sandberg AL, Obrist R, Mergenhagen SE.

Agents Actions Suppl. 1983;12:234-50. Review. No abstract available.

PMID:
6340437
28.

In vitro effects of antitumor antibody--chemotactic factor complexes.

Obrist R, Sandberg AL.

Clin Immunol Immunopathol. 1982 Oct;25(1):91-102. No abstract available.

PMID:
6295673
29.
30.

Activation of serum complement inhibits collagen synthesis in fetal rat bone in organ culture.

Kream BE, Raisz LG, Sandberg AL.

Calcif Tissue Int. 1982 Jul;34(4):370-5.

PMID:
6814726
31.

Enhancement of complement-mediated prostaglandin synthesis and bone resorption by arachidonic acid and inhibition by cortisol.

Sandberg AL, Raisz LG, Wahl LM, Simmons HA.

Prostaglandins Leukot Med. 1982 May;8(5):419-27.

PMID:
6808524
32.

Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.

Cisar JO, Barsumian EL, Curl SH, Vatter AE, Sandberg AL, Siraganian RP.

J Immunol. 1981 Oct;127(4):1318-22.

PMID:
6115881
33.

The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.

Cisar JO, Barsumian EL, Curl SH, Vatter AE, Sandberg AL, Siraganian RP.

J Reticuloendothel Soc. 1980 Dec;28(Suppl):73s-79s. No abstract available.

PMID:
6108369
34.

Direct stimulation of bone resorption by epidermal growth factor.

Raisz LG, Simmons HA, Sandberg AL, Canalis E.

Endocrinology. 1980 Jul;107(1):270-3.

PMID:
6966568
35.

Characterization of mouse allergens.

Siraganian RP, Sandberg AL.

J Allergy Clin Immunol. 1979 Jun;63(6):435-42.

PMID:
109484
36.

Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations.

Wahl LM, Rosenstreich DL, Glode LM, Sandberg AL, Mergenhagen SE.

Infect Immun. 1979 Jan;23(1):8-13.

37.

Prostaglandin and cyclic AMP regulation of macrophage involvement in connective tissue destruction.

Wahl LM, Olsen CE, Wahl SM, McCarthy JB, Sandberg AL, Mergenhagen SE.

Ann N Y Acad Sci. 1979;332:271-8. No abstract available.

PMID:
93863
38.

Chemotactic antibody.

Isturiz MA, Sandberg AL, Schiffmann E, Wahl SM, Notkins AL.

Science. 1978 May 5;200(4341):554-6.

PMID:
205950
39.

Prostaglandin regulation of macrophage collagenase production.

Wahl LM, Olsen CE, Sandberg AL, Mergenhagen SE.

Proc Natl Acad Sci U S A. 1977 Nov;74(11):4955-8.

40.

Initiation of bone resorption by the classical and alternative C pathways and its mediation by prostaglandins.

Sandberg AL, Raisz LG, Goodson JM, Simmons HA, Mergenhagen SE.

J Immunol. 1977 Oct;119(4):1378-81.

PMID:
894043
41.
43.

Lymphokine production by C3b-stimulated B cells.

Sandberg AL, Wahl SM, Mergenhagen SE.

J Immunol. 1975 Jul;115(1):139-44.

PMID:
1080163
44.

Complement-dependent stimulation of prostaglandin synthesis and bone resorption.

Raisz LG, Sandberg AL, Goodson JM, Simmons HA, Mergenhagen SE.

Science. 1974 Aug 30;185(4153):789-91.

PMID:
4843377
45.

Platelet injury due to activation of the alternate complement pathway.

Siraganian RP, Sandberg AL, Alexander A, Osler AG.

J Immunol. 1973 Feb;110(2):490-7. No abstract available.

PMID:
4119252
46.

Alternate complement pathways.

Osler AG, Sandberg AL.

Prog Allergy. 1973;17(0):51-92. Review. No abstract available.

PMID:
4277357
47.

Lysis of rabbit platelets by F(ab') 2 antibody fragments.

Siraganian RP, Sandberg AL, Osler AG.

J Immunol. 1972 Oct;109(4):907-9. No abstract available.

PMID:
4116363
48.

Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway.

Sandberg AL, Snyderman R, Frank MM, Osler AG.

J Immunol. 1972 May;108(5):1227-31. No abstract available.

PMID:
5029138
49.

Dual pathways of complement interaction with guinea pig immunoglobulins.

Sandberg AL, Osler AG.

J Immunol. 1971 Nov;107(5):1268-73. No abstract available.

PMID:
5117668
50.

Complement utilization by guinea pig 1 and 2-immunoglobulins through the C3 activator system.

Sandberg AL, Götze O, Müller-Eberhard HJ, Osler AG.

J Immunol. 1971 Sep;107(3):920-3. No abstract available.

PMID:
4105938

Supplemental Content

Loading ...
Support Center